MedPath

Imotab

Brand Name: Imotab

Generic Name: Loperamide Hydrochloride

Active
Registration Number

DRP-4378

Dosage Form

Capsule

Issuance Date

January 31, 2023

Expiry Date

March 18, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2mg
PackagingAlu/Clear Pvc Blister Pack X 10'S (Box Of 30'S And 100'S)

Classification

C
Classification
Over-The-Counter (OTC)
P
Pharmacologic
Antimotility
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Loperamide HydrochlorideActive
Monograph: Loperamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform